Advertisement
Screener

bioAffinity Technologies, Inc. (BIAF) Graph

2.4 / 5 stars · 17/35 Roast Me

Add as a preferred source on Google

BIAF Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $1.51M; Cost of revenue (m); Research and development $361.57K; Selling, general and administrative $2.86M.
  • 2026-03-31: Revenue $1.35M; Cost of revenue (m); Research and development $349.71K; Selling, general and administrative $3.24M.
  • 2025-12-31: Revenue $1.59M*; Cost of revenue (m); Research and development $374.01K*; Selling, general and administrative $3.04M*.
  • 2025-09-30: Revenue $1.45M; Cost of revenue (m); Research and development $330.59K; Selling, general and administrative $2.21M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

BIAF revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Histology Service Fees$248.26KLaboratory Services$1.51MMedical Director Fees$17.54KOther Revenues$633.00Health CarePatient Service$1.24MRevenue$1.51MOperating expenses$4.85MOperating income-$3.33MResearch & development$361.58KSelling, general& administrative$2.86MPre-tax income-$3.37MNet income-$3.37M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$1.51M(m)$361.57K$2.86M$4.85M(m)-$3.37M
2026-03-31$1.35M(m)$349.71K$3.24M$4.97M(m)-$3.63M
2025-12-31$1.59M*(m)$374.01K*$3.04M*$4.73M*$3.18K*-$3.14M*
2025-09-30$1.45M(m)$330.59K$2.21M$3.74M$3.18K-$5.05M
2025-06-30$1.27M(m)$311.37K$2.21M$3.79M$28.98K-$4.06M
2025-03-31$1.85M(m)$367.39K$2.45M$4.48M$8.70K-$2.66M
2024-09-30$2.35M(m)$274.50K$2.36M$4.32M$2.56K-$2.00M
2024-06-30$2.40M(m)$402.43K$2.47M$4.49M$5.42K-$2.11M
2024-03-31$2.41M(m)$393.64K$2.19M$4.35M$3.67K-$1.96M
2023-09-30$298.48K$74.70K$330.38K$2.02M$2.59M$2.29K-$2.29M
2023-06-30$19.74K$1.23K$335.13K$1.40M$1.80M$4.59K-$1.74M
2023-03-31(m)$87.00$369.62K$1.15M$1.56M$11.82K-$1.53M
2022-09-30$1.15K$146.00$319.74K$595.70K$977.16K$300.00-$4.92M
2022-06-30$1.31K$146.00$248.42K$408.62K$685.28K(m)-$88.05K
2022-03-31(m)(m)$279.85K$394.69K$727.04K$2.16K-$1.47M
2021-09-30(m)(m)$330.77K(m)$526.29K(m)-$1.51M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$2.86M(m)$711.28K$6.10M$9.81M(m)-$7.00M
2025-06-30$3.12M(m)$678.76K$4.67M$8.27M$37.68K-$6.72M
2024-06-30$4.80M(m)$796.07K$4.66M$8.84M$9.09K-$4.07M
2023-06-30(m)$1.32K$704.74K$2.55M$3.36M$16.41K-$3.27M
2022-06-30$1.31K$146.00$528.27K$803.31K$1.41M$2.16K-$1.56M
2021-06-30(m)(m)(m)(m)(m)(m)$764.27K

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$4.57M(m)$1.01M$6.88M$12.00M$40.86K-$11.77M
2024-09-30$7.15M(m)$1.07M$7.02M$13.16M$11.65K-$6.07M
2023-09-30(m)$76.03K$1.04M$4.58M$5.95M$18.70K-$5.56M
2022-09-30$2.46K$292.00$949.39K$1.30M$2.39M$2.46K-$6.48M
2021-09-30(m)(m)$877.67K(m)$1.55M$1.95K-$749.52K

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$6.16M(m)$1.38M$9.91M$16.73M$44.04K-$14.91M
2024-12-31$9.36M(m)$1.46M$9.94M$18.32M$11.65K-$9.04M
2023-12-31$2.53M(m)$1.47M$6.79M$10.51M$20.99K-$7.94M
2022-12-31(m)$467.00$1.38M$2.48M$4.02M$2.46K-$8.15M
2021-12-31(m)(m)$1.01M$1.07M$2.21M$1.95K-$6.33M

Similar stocks

Stock NameCountryMarket CapPE Ratio
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
NRC HEALTH (NRC)United States$0.450B42.50
OmniAb, Inc. (OABI)United States$0.698B-8.05
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Advertisement